Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 88,039 | 18,474 | 7,530 | 94,588 | 70,428 |
| Gross Profit | 88,039 | 18,474 | 7,530 | 94,588 | 70,428 |
| Operating Expenses | 700,297 | 554,722 | 503,735 | 418,790 | 256,741 |
| Operating Income | -612,258 | -536,248 | -496,205 | -324,202 | -186,313 |
| Interest Expense | 103,868 | 86,512 | 57,668 | 51,156 | 29,332 |
| Other Income | -68,829 | 33,234 | 27,629 | -13,597 | 331 |
| Pre-tax Income | -784,955 | -589,526 | -526,244 | -388,955 | -215,314 |
| Net Income Continuous | -784,955 | -589,526 | -526,244 | -388,955 | -215,314 |
| Net Income | $-784,955 | $-589,526 | $-526,244 | $-388,955 | $-215,314 |
| EPS Basic Total Ops | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| EPS Basic Continuous Ops | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| EPS Diluted Total Ops | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| EPS Diluted Continuous Ops | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| EPS Diluted Before Non-Recurring Items | N/A | -5.26 | -5.45 | -4.06 | -2.80 |
| EBITDA(a) | $-602,133 | $-526,717 | $-484,313 | $-318,388 | $-184,037 |